EA199700419A1 - Вакцинная композиция, содержащая полирибозилрибитолфосфат, и способ ее получения - Google Patents

Вакцинная композиция, содержащая полирибозилрибитолфосфат, и способ ее получения

Info

Publication number
EA199700419A1
EA199700419A1 EA199700419A EA199700419A EA199700419A1 EA 199700419 A1 EA199700419 A1 EA 199700419A1 EA 199700419 A EA199700419 A EA 199700419A EA 199700419 A EA199700419 A EA 199700419A EA 199700419 A1 EA199700419 A1 EA 199700419A1
Authority
EA
Eurasian Patent Office
Prior art keywords
vaccine composition
composition containing
polyribosilribitolphosphate
preparation
aluminum
Prior art date
Application number
EA199700419A
Other languages
English (en)
Other versions
EA000411B1 (ru
Inventor
Франсуа Арменжон
Жан-Рене Картье
Original Assignee
Пастёр Мерьё Серён Э Ваксен С.А.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9479510&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EA199700419(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Пастёр Мерьё Серён Э Ваксен С.А. filed Critical Пастёр Мерьё Серён Э Ваксен С.А.
Publication of EA199700419A1 publication Critical patent/EA199700419A1/ru
Publication of EA000411B1 publication Critical patent/EA000411B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/831—Drug, bio-affecting and body treating compositions involving capsular polysaccharide of bacterium, e.g. polyribosyl ribitol phosphate

Abstract

Вакцинная композиция, содержащая один или более антигенов, включающих высокомолекулярный капсулированный полисахарид Haemophilus гриппа типа b или полирибозилрибитолфосфат, связанный со столбнячным анатоксином, и адъювант на основе алюминия, при этом адъювант на основе алюминия в своем природном виде или после присоединения аниона имеет точку нулевого заряда ниже 7,2. Описан также способ получения указанной вакцинной композиции.Международная заявка была опубликована вместе с отчетом о международном поиске.
EA199700419A 1995-05-24 1996-05-24 Вакцинная композиция, содержащая полирибозилрибитолфосфат, и способ ее получения EA000411B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9506417A FR2734484B1 (fr) 1995-05-24 1995-05-24 Composition vaccinale liquide et procede de fabrication
PCT/FR1996/000791 WO1996037222A1 (fr) 1995-05-24 1996-05-24 Composition vaccinale comprenant du polyribosylribitol phosphate et son procede de fabrication

Publications (2)

Publication Number Publication Date
EA199700419A1 true EA199700419A1 (ru) 1998-06-25
EA000411B1 EA000411B1 (ru) 1999-06-24

Family

ID=9479510

Family Applications (1)

Application Number Title Priority Date Filing Date
EA199700419A EA000411B1 (ru) 1995-05-24 1996-05-24 Вакцинная композиция, содержащая полирибозилрибитолфосфат, и способ ее получения

Country Status (26)

Country Link
US (1) US6333036B1 (ru)
EP (1) EP0828511B1 (ru)
JP (1) JPH11505824A (ru)
KR (1) KR100404312B1 (ru)
CN (1) CN1152715C (ru)
AT (1) ATE207365T1 (ru)
BR (1) BR9608810C8 (ru)
CA (1) CA2218764C (ru)
CZ (1) CZ289810B6 (ru)
DE (2) DE122011100030I1 (ru)
DK (1) DK0828511T3 (ru)
EA (1) EA000411B1 (ru)
ES (1) ES2162067T3 (ru)
FR (1) FR2734484B1 (ru)
GR (1) GR3037011T3 (ru)
HK (1) HK1017251A1 (ru)
HU (1) HU223941B1 (ru)
LU (1) LU91924I2 (ru)
NL (1) NL300231I2 (ru)
NO (2) NO319579B1 (ru)
NZ (1) NZ309829A (ru)
PL (1) PL185846B1 (ru)
PT (1) PT828511E (ru)
SK (1) SK282500B6 (ru)
TR (1) TR199701424T1 (ru)
WO (1) WO1996037222A1 (ru)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020054884A1 (en) 1995-06-23 2002-05-09 Smithkline Beecham Biologicals, Sa Vaccine composition comprising a polysaccharide conjugate antigen adsorbed onto aluminium phosphate
US6974581B1 (en) * 1998-12-15 2005-12-13 Aventis Pasteur Limited Multi-component vaccine comprising at least two antigens from haemophilus influenzae to protect against disease
IL145209A0 (en) 2000-09-06 2002-06-30 Pfizer Prod Inc Pharmaceutical combinations for the treatment of stroke and traumatic brain injury
EP1674087A1 (en) 2000-10-02 2006-06-28 Pfizer Products Inc. Prophylactic use of n-methyl-d-aspartate (NMDA) antagonists
FR2828406B1 (fr) * 2001-08-08 2005-06-24 Aventis Pasteur Composition vaccinale bivalente havi
ES2608048T3 (es) 2002-10-11 2017-04-05 Glaxosmithkline Biologicals Sa Vacunas polipeptídicas para protección amplia contra linajes meningocócicos hipervirulentos
CA2514328C (en) 2003-01-30 2020-01-14 Chiron Srl Injectable vaccines against multiple meningococcal serogroups
GB0313916D0 (en) 2003-06-16 2003-07-23 Glaxosmithkline Biolog Sa Vaccine composition
GB0323103D0 (en) 2003-10-02 2003-11-05 Chiron Srl De-acetylated saccharides
DK1961426T3 (da) 2003-10-02 2011-08-08 Novartis Ag Kombinationsvacciner mod meningitis
ATE473967T1 (de) * 2003-11-26 2010-07-15 Pfizer Prod Inc Aminopyrazolderivate als gsk-3-inhibitoren
GB0405787D0 (en) * 2004-03-15 2004-04-21 Chiron Srl Low dose vaccines
GB0409745D0 (en) 2004-04-30 2004-06-09 Chiron Srl Compositions including unconjugated carrier proteins
GB0500787D0 (en) 2005-01-14 2005-02-23 Chiron Srl Integration of meningococcal conjugate vaccination
RU2379052C2 (ru) 2004-04-30 2010-01-20 Чирон С.Р.Л. Вакцинация менингококковыми конъюгатами
CN105147611A (zh) * 2007-07-26 2015-12-16 圣诺菲·帕斯图尔有限公司 抗原佐剂组合物及其方法
GB0818453D0 (en) 2008-10-08 2008-11-12 Novartis Ag Fermentation processes for cultivating streptococci and purification processes for obtaining cps therefrom
PE20100365A1 (es) * 2008-10-24 2010-05-21 Panacea Biotec Ltd Novedosas vacunas de combinacion con tos ferina de celulas enteras y metodo para su elaboracion
PE20100366A1 (es) * 2008-10-24 2010-05-21 Panacea Biotec Ltd Novedosas composiciones de vacuna con tos ferina acelular asi como el metodo para su elaboracion
US7814991B2 (en) * 2009-01-28 2010-10-19 Gas Technology Institute Process and apparatus for subterranean drilling
AU2010227219B2 (en) 2009-03-24 2014-02-27 Glaxosmithkline Biologicals S.A. Adjuvanting meningococcal factor H binding protein
SG10201505374TA (en) * 2010-03-29 2015-08-28 Novartis Ag Composition comprising the amyloid beta 1-6 peptide coupled to a virus-like particle and an adjuvant
CN103442730B (zh) 2011-01-05 2016-08-17 巴拉特生物技术国际有限公司 组合七价疫苗
KR102236498B1 (ko) 2013-03-08 2021-04-06 얀센 백신스 앤드 프리벤션 비.브이. 무세포 백일해 백신
EP4327820A1 (en) 2021-04-20 2024-02-28 KM Biologics Co., Ltd. Liquid sextuple vaccine composition

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1209036A (en) * 1982-08-20 1986-08-05 Joseph S.C. Kuo Combined haemophilus influenzae and diphtheria, pertussis, tetanus vaccine
IT1187753B (it) * 1985-07-05 1987-12-23 Sclavo Spa Coniugati glicoproteici ad attivita' immunogenica trivalente
EP0320942A3 (en) * 1987-12-18 1989-10-04 American Cyanamid Company Novel polysaccharides novel macromolecular conjugates of the polysaccharides
GB9202219D0 (en) * 1992-02-03 1992-03-18 Connaught Lab A synthetic heamophilus influenzae conjugate vaccine
DK0835663T3 (da) * 1992-05-23 2010-02-01 Glaxosmithkline Biolog Sa Kombinerede vacciner omfattende Hepatitis B overfladeantigen og andre antigener

Also Published As

Publication number Publication date
SK152997A3 (en) 1998-07-08
FR2734484A1 (fr) 1996-11-29
NO2011019I1 (no) 2011-09-26
NZ309829A (en) 1999-06-29
NO975366L (no) 1997-11-21
PL185846B1 (pl) 2003-08-29
AU6008696A (en) 1996-12-11
DE69620271D1 (de) 2002-05-02
US6333036B1 (en) 2001-12-25
GR3037011T3 (en) 2002-01-31
KR19990014919A (ko) 1999-02-25
CA2218764A1 (fr) 1996-11-28
HU223941B1 (hu) 2005-03-29
DE69620271T2 (de) 2002-07-18
KR100404312B1 (ko) 2004-02-11
NL300231I2 (nl) 2006-09-01
DE122011100030I1 (de) 2011-12-08
CN1190898A (zh) 1998-08-19
MX9709011A (es) 1998-03-31
PL323457A1 (en) 1998-03-30
CN1152715C (zh) 2004-06-09
NO319579B1 (no) 2005-08-29
FR2734484B1 (fr) 1997-06-27
NL300231I1 (nl) 2006-07-03
NO975366D0 (no) 1997-11-21
TR199701424T1 (xx) 1998-03-21
AU708777B2 (en) 1999-08-12
JPH11505824A (ja) 1999-05-25
BR9608810A (pt) 1999-08-31
LU91924I2 (fr) 2012-02-21
DK0828511T3 (da) 2002-02-18
HUP9901432A3 (en) 2000-03-28
ATE207365T1 (de) 2001-11-15
EP0828511A1 (fr) 1998-03-18
NO2011019I2 (no) 2015-05-18
WO1996037222A1 (fr) 1996-11-28
HK1017251A1 (en) 1999-11-19
CZ289810B6 (cs) 2002-04-17
ES2162067T3 (es) 2001-12-16
HUP9901432A2 (hu) 1999-08-30
BR9608810C8 (pt) 2014-07-08
SK282500B6 (sk) 2002-10-08
CZ359797A3 (cs) 1999-06-16
CA2218764C (fr) 2011-01-11
PT828511E (pt) 2002-02-28
EP0828511B1 (fr) 2001-10-24
EA000411B1 (ru) 1999-06-24

Similar Documents

Publication Publication Date Title
EA199700419A1 (ru) Вакцинная композиция, содержащая полирибозилрибитолфосфат, и способ ее получения
MC2178A1 (fr) Mutants de la pneumolysine et vaccins a base de pneumocoque prepares a partir de ces mutants
PL291855A1 (en) Method of obtaining covalent conjugate of oligosaccharide with proteinous support
ATE19734T1 (de) Heamophilus influenzae b polysaccharid exotoxoid konjugat-impfstoff.
IE840197L (en) Polysaccharide protein conjugate vaccine
MY133981A (en) Vaccine composition
IS3753A7 (is) Endurbætt aðferð og samsetning bóluefnis
BRPI9710460B8 (pt) composição imunogênica multi-valente e composição de vacina
ES8608883A1 (es) Procedimiento de preparacion de un conjugado de muramilpeptido y de un hapteno o fragmento haptenico de bajo peso molecular.
AU3313789A (en) Haemophilus influenza type B oxidized polysaccharide-outer membrane protein conjugate vaccine
ES8401722A1 (es) Procedimiento de obtencion de vacunas contra el patogeno h influenzae tipo b.
AU3760795A (en) Synthesis of typhoid fever vaccine from a plant or fruit polysaccharide
UA27754C2 (ru) Комбинированная педиатрическая вакцина, способ одновременной комбинированной вакцинации
WO1990015132A3 (en) Cloned treponema hyodysenteriae endoflagellar antigen

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ KZ KG MD TJ TM

MK4A Patent expired

Designated state(s): BY RU